Can genes predict COPD attacks? new study seeks answers

NCT ID NCT03450603

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find risk factors—including genetic ones—that make some COPD patients more likely to have severe flare-ups. Researchers will follow 200 adults with COPD to see which ones have acute exacerbations. The goal is to help doctors personalize treatment and prevent serious episodes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help doctors identify which COPD patients need closer monitoring or more intensive care to prevent severe flare-ups.

What could go wrong

This is an observational study, not a treatment trial. It may not find clear risk factors, and any findings would need further testing before changing patient care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Respiratory Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

    RECRUITING

    Shanghai, 200092, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••